Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Status:
Recruiting
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to see if Loncastuximab Tesirine in combination with
Rituximab will result in higher complete response rate when given to treat follicular
lymphoma.